COLL Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Collegium Pharmaceutical Inc

Watchlist Manager

Watchlist

Price: 27.25 USD -1.05%

Market Cap: $883.7m

	Collegium Pharmaceutical Inc NASDAQ:COLL	US
O	OCI NV OTC:OCINF	NL
	Banneker Inc OTC:BANI	US
B	Biolight Life Sciences Ltd TASE:BOLT	IL
P	Proactis SA PAR:PROAC	FR
	Vaxcyte Inc NASDAQ:PCVX	US
	Neosperience SpA MIL:NSP	IT
	Optare Solutions SA MAD:OPTS	ES
B	Bank Millennium SA F:1HN	PL
	Shockwave Medical Inc F:36M	US
	IP Group PLC LSE:IPO	UK
	Bintang Oto Global Tbk PT IDX:BOGA	ID
K	Knight Therapeutics Inc OTC:KHTRF	CA
	Lite Access Technologies Inc F:LA7	CA
T	Taokaenoi Food & Marketing PCL SET:TKN	TH
I	I&I Group PCL SET:IIG	TH
	J B Hunt Transport Services Inc NASDAQ:JBHT	US
	Medondo Holding AG F:AMI	DE
	R1 RCM Holdco Inc F:6HL0	US
S	SAB Finance as PSE:SABFG	CZ

Profitability Summary

Collegium Pharmaceutical Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

60%

Strong 3Y Average Gross Margin

59%

Gross Margin is Increasing

49% > 60%

Healthy Operating Margin

18%

Sustainable 3Y Average Operating Margin

25%

Declining Operating Margin

20% > 18%

Low Net Margin

Low 3Y Average Net Margin

Net Margin is Increasing

-2% > 6%

Exceptional Free Cash Flow Margin

41%

Strong 3Y Average Free Cash Flow Margin

40%

Declining Free Cash Flow Margin

44% > 41%

Positive ROE

18%

Exceptional 3Y Average ROE

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.